Mannkind CorpMNKD

NasdaqHealthcarePharmaceutical Preparations
Price (close)
$3.29
Market cap
$1.1B
P/E
—
Revenue (TTM)
$393.6M
Net income
-$43.6M
Dividend yield
—
1-year total return
-38.3%
Net margin
-11.1%
Revenue growth
30.5%
Debt / equity
—

What Mannkind Corp does.

No business description on file yet.

Revenue and profit, by fiscal year.

Fiscal year202020212022202320242025
Revenue$65.1M$75.4M$99.8M$199.0M$285.5M$349.0M
Net income-$57.2M-$80.9M-$87.4M-$11.9M$27.6M$5.9M
Free cash flow-$28.9M-$73.2M-$88.3M-$8.3M$32.8M$13.7M

More on MNKD.

Figures from Mannkind Corp's filings with the U.S. SEC, standardised automatically; prices are end-of-day closes. Not financial advice.